The U.S. Food and Drug Administration (FDA) has introduced a proposal for a rule that sets unified testing procedures to identify asbestos in cosmetics containing talc. Initiated under the Modernization of Cosmetics Regulation Act of 2022 (MoCRA), this proposal focuses on tighter safety protocols aimed at minimizing exposure to the carcinogenic substance.
This proposed rule, called “Testing Methods for Detecting and Identifying Asbestos in Talc-Containing Cosmetic Products,” calls for the use of both Polarized Light Microscopy (PLM) and Transmission Electron Microscopy/Energy Dispersive Spectroscopy/Selected Area Electron Diffraction (TEM/EDS/SAED). These techniques, recommended by the Interagency Working Group on Asbestos in Consumer Products (IWGACP), have been previously described in academic research made public in 2022.
Talc’s extensive application in cosmetics over many years highlights the necessity of this proposal due to the potential presence of asbestos, a well-documented health hazard linked to cancer. By instituting consistent safety measures, this rule aims to protect consumers by minimizing asbestos exposure and associated illnesses. It also encourages manufacturers to comply, aiding in the avoidance of product recalls and fostering renewed consumer confidence in talc-based products.